Watching for the bounce.
http://stockcharts.com/h-sc/ui?s=CRY...1375&listNum=3
CryoLife Inc.
1655 Roberts Boulevard NW
Kennesaw, GA 30144
United States - Map
Phone: 770-419-3355
Fax: 770-952-9743
Web Site:
http://www.cryolife.com
DETAILS
Index Membership: S&P 600 SmallCap
S&P 1500 Super Comp
Sector: Healthcare
Industry: Medical Appliances & Equipment
Full Time Employees: 388
BUSINESS SUMMARY
CryoLife, Inc. engages in the development and commercialization of biomaterials and implantable medical devices. Its biomaterials and implantable devices include BioGlue surgical adhesive, porcine heart valves, and vascular grafts of bovine tissue. The company's product BioGlue, a polymer based on bovine blood protein and an agent for cross-linking proteins, is designed for cardiovascular, vascular, pulmonary, and general surgical applications, as well as used as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. It markets BioGlue to physicians and distributes it through its technical representatives in the United States and Europe, as well as for soft tissue repairs in Canada. The company also distributes preserved human cardiovascular, vascular, and orthopedic tissue to implanting institutions in the United States, Canada, and Europe. In addition, it markets porcine heart valve, the O'Brien aortic heart valve, and the SynerGraft bovine vascular graft to cardiac surgeons in Europe, the Middle East, and Africa. CryoLife has an agreement with the Cleveland Clinic to develop an allograft or human tissue heart valve for patients suffering from serious heart infections. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Shares Outstanding: 25.11M
Float: 22.05M
% Held by Insiders: 10.59%
% Held by Institutions: 45.00%